Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol : A Preliminary Feasibility Study
Background and Aims: A preliminary study compared the use of continuous glucose monitoring (CGM) with the use of self-monitored blood glucose (SMBG) by aircraft pilots with insulin-treated diabetes in the United Kingdom, Ireland, and Austria, certified to fly commercial aircraft within the European Aviation Safety Agency ARA.MED.330 protocol. Methods: SMBG and simultaneous interstitial glucose measurements using CGM (Dexcom G6®) were recorded during pre- and in-flight periods. Results: Eight male pilots (seven with type 1 diabetes and one with type 3c diabetes), median age of 48.5 years and median diabetes duration of 11.5 years, participated. The correlation coefficient (R) between 874 contemporaneously recorded SMBG and CGM values was 0.843, P < 0.001. The mean glucose concentration was 8.78 mmol/L (standard deviation [SD] 0.67) using SMBG compared with 8.71 mmol/L (SD 0.85) recorded using CGM. The mean absolute relative difference was 9.39% (SD 3.12). Conclusions: CGM using Dexcom G6 systems is a credible alternative to SMBG for monitoring glucose levels when insulin-treated pilots fly commercial aircraft. The study was registered with Clinical Trials.gov NCT04395378.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Diabetes technology & therapeutics - 25(2023), 8 vom: 27. Aug., Seite 543-548 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garden, Gillian L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Airline pilots |
|---|
| Anmerkungen: |
Date Completed 03.08.2023 Date Revised 04.08.2023 published: Print ClinicalTrials.gov: NCT04395378 Citation Status MEDLINE |
|---|
| doi: |
10.1089/dia.2023.0069 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358861292 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358861292 | ||
| 003 | DE-627 | ||
| 005 | 20231226075639.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/dia.2023.0069 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1196.xml |
| 035 | |a (DE-627)NLM358861292 | ||
| 035 | |a (NLM)37384853 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garden, Gillian L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol |b A Preliminary Feasibility Study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.08.2023 | ||
| 500 | |a Date Revised 04.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ClinicalTrials.gov: NCT04395378 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background and Aims: A preliminary study compared the use of continuous glucose monitoring (CGM) with the use of self-monitored blood glucose (SMBG) by aircraft pilots with insulin-treated diabetes in the United Kingdom, Ireland, and Austria, certified to fly commercial aircraft within the European Aviation Safety Agency ARA.MED.330 protocol. Methods: SMBG and simultaneous interstitial glucose measurements using CGM (Dexcom G6®) were recorded during pre- and in-flight periods. Results: Eight male pilots (seven with type 1 diabetes and one with type 3c diabetes), median age of 48.5 years and median diabetes duration of 11.5 years, participated. The correlation coefficient (R) between 874 contemporaneously recorded SMBG and CGM values was 0.843, P < 0.001. The mean glucose concentration was 8.78 mmol/L (standard deviation [SD] 0.67) using SMBG compared with 8.71 mmol/L (SD 0.85) recorded using CGM. The mean absolute relative difference was 9.39% (SD 3.12). Conclusions: CGM using Dexcom G6 systems is a credible alternative to SMBG for monitoring glucose levels when insulin-treated pilots fly commercial aircraft. The study was registered with Clinical Trials.gov NCT04395378 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Airline pilots | |
| 650 | 4 | |a Continuous glucose monitoring | |
| 650 | 4 | |a Flying | |
| 650 | 4 | |a Insulin-treated diabetes | |
| 650 | 7 | |a Insulin |2 NLM | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Insulin, Regular, Human |2 NLM | |
| 700 | 1 | |a Shojaee-Moradie, Fariba |e verfasserin |4 aut | |
| 700 | 1 | |a Hutchison, Ewan J |e verfasserin |4 aut | |
| 700 | 1 | |a Frier, Brian M |e verfasserin |4 aut | |
| 700 | 1 | |a Shaw, Kenneth M |e verfasserin |4 aut | |
| 700 | 1 | |a Heller, Simon R |e verfasserin |4 aut | |
| 700 | 1 | |a Koehler, Gerd |e verfasserin |4 aut | |
| 700 | 1 | |a Mader, Julia K |e verfasserin |4 aut | |
| 700 | 1 | |a Maher, Declan |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, Graham A |e verfasserin |4 aut | |
| 700 | 1 | |a Russell-Jones, David L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes technology & therapeutics |d 1999 |g 25(2023), 8 vom: 27. Aug., Seite 543-548 |w (DE-627)NLM113690495 |x 1557-8593 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2023 |g number:8 |g day:27 |g month:08 |g pages:543-548 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1089/dia.2023.0069 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2023 |e 8 |b 27 |c 08 |h 543-548 | ||